World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
62
Citations
28015
World Ranking
3086
National Ranking
1445

David G. DeNardo publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where David G. DeNardo sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 219 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

David G. DeNardo D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where David G. DeNardo sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 62 D-Index — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

David G. DeNardo is affiliated with Washington University in St. Louis in the United States. Their research focuses broadly on medicine, immunology and microbiology, and biochemistry, genetics, and molecular biology. Within these fields, specific areas of study include oncology, immunology, molecular biology, cancer research, and pulmonary and respiratory medicine.

They have contributed significantly to multiple main research topics including cancer immunotherapy and biomarkers, pancreatic and hepatic oncology research, immune cells in cancer, CAR-T cell therapy research, cancer genomics and diagnostics, immunotherapy and immune responses, and cancer cells and metastasis.

David G. DeNardo has published numerous papers in a range of scientific journals. Recent publications include:

  • A framework for advancing our understanding of cancer-associated fibroblasts (2020), published in Nature Reviews. Cancer
  • Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer (2020), published in Cancer Cell
  • Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer (2022), published in Nature Genetics
  • Epigenetic regulation during cancer transitions across 11 tumour types (2023), published in Nature
  • Rethinking immune checkpoint blockade: 'Beyond the T cell' (2021), published in Journal for ImmunoTherapy of Cancer

The venues where David G. DeNardo publishes frequently include Cancer Research, bioRxiv (Cold Spring Harbor Laboratory), Cancer Discovery, Clinical Cancer Research, and Cancer Cell. These journals reflect a consistent engagement with cancer-focused and immunology-related scientific communities.

Throughout their career, they have collaborated extensively with several researchers. Their frequent coauthors are:

  • Ryan C. Fields
  • William G. Hawkins
  • Brett L. Knolhoff
  • John Baer
  • Liang-I Kang

Best Publications

  • Macrophages as regulators of tumour immunity and immunotherapy

    David G. DeNardo;Brian Ruffell

  • Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy

    David G. DeNardo;David G. DeNardo;Donal J. Brennan;Elton Rexhepaj;Brian Ruffell

  • CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of Macrophages

    David G. DeNardo;Jairo B. Barreto;Pauline Andreu;Lesley Vasquez;Lesley Vasquez

  • CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models

    Yu Zhu;Brett L. Knolhoff;Melissa A. Meyer;Timothy M. Nywening

  • Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses

    Jonathan B Mitchem;Donal J Brennan;Brett L Knolhoff;Brian A Belt

  • Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy

    Hong Jiang;Samarth Hegde;Brett L Knolhoff;Yu Zhu

  • Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression.

    David G DeNardo;Lisa M Coussens

  • Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression

    Yu Zhu;John M. Herndon;Dorothy K. Sojka;Ki Wook Kim

  • Macrophage Expression of Hypoxia-Inducible Factor-1α Suppresses T-Cell Function and Promotes Tumor Progression

    Andrew L. Doedens;Christian Stockmann;Mark P. Rubinstein;Debbie Liao

  • Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity.

    David G. DeNardo;Pauline Andreu;Lisa M. Coussens

  • FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis

    Pauline Andreu;Magnus Johansson;Nesrine I. Affara;Ferdinando Pucci

  • Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis

    Dominic E. Sanford;Brian A. Belt;Roheena Z. Panni;Allese Mayer

  • The Human Tumor Atlas Network: Charting Tumor Transitions Across Space and Time at Single-Cell Resolution

    Orit Rozenblatt-Rosen;Aviv Regev;Aviv Regev;Aviv Regev;Philipp Oberdoerffer;Tal Nawy

  • Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis

    Megan K. Ruhland;Andrew J. Loza;Aude Helene Capietto;Xianmin Luo

  • Immune cells as mediators of solid tumor metastasis.

    David G. DeNardo;Magnus Johansson;Lisa M. Coussens

  • Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma

    Timothy M Nywening;Brian A Belt;Darren R Cullinan;Roheena Z Panni

  • Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer.

    Samarth Hegde;Varintra E. Krisnawan;Brett H. Herzog;Chong Zuo

  • Lymphocytes in cancer development: Polarization towards pro-tumor immunity

    Brian Ruffell;David G. DeNardo;Nesrine I. Affara;Lisa M. Coussens

  • TH2-Polarized CD4+ T Cells and Macrophages Limit Efficacy of Radiotherapy

    Stephen L. Shiao;Brian Ruffell;David G. DeNardo;Bruce A. Faddegon

  • Polarized immune responses differentially regulate cancer development.

    Magnus Johansson;David G. DeNardo;Lisa M. Coussens

  • Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner.

    Lisa Volk-Draper;Kelly Hall;Caitlin Griggs;Sandeep Rajput

  • Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression

    David G DeNardo;Lisa M Coussens

  • Correction: Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression (Immunity (2017) 47(2) (323–338.e6) (S1074761317303217)(10.1016/j.immuni.2017.07.014))

    Yu Zhu;John M. Herndon;Dorothy K. Sojka;Ki Wook Kim

Frequent Co-Authors

William G. Hawkins
William G. Hawkins Washington University in St. Louis
Lisa M. Coussens
Lisa M. Coussens Oregon Health & Science University
William E. Gillanders
William E. Gillanders Washington University in St. Louis
Roberta Faccio
Roberta Faccio Washington University in St. Louis
Lorenzo Galluzzi
Lorenzo Galluzzi Cornell University
Brian L. West
Brian L. West Daiichi Sankyo (United States)
Samuel Achilefu
Samuel Achilefu Washington University in St. Louis
Susan G. Hilsenbeck
Susan G. Hilsenbeck Baylor College of Medicine
Aviv Regev
Aviv Regev Genentech
Li Ding
Li Ding Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related nursing degrees online can be a strategic step towards a rewarding healthcare career. Many professionals start by exploring online RN programs for non nurses in Florida, which provide foundational nursing skills even without prior healthcare experience.

Once registered nurses, individuals often advance through accelerated nurse practitioner programs. These programs shorten the pathway to becoming a nurse practitioner, allowing quicker entry into specialized roles that intersect with immunology research and clinical practice.

Further specialization is possible with certifications like acute care nurse practitioner certification. This credential enables practitioners to work in critical care settings, which often involve immunological assessments and treatments for complex patient cases.

Understanding the financial outlook is also important. According to dnp salary data, salaries vary significantly by location, reflecting demand and cost of living factors. This insight helps aspiring professionals make informed decisions about their education and career pathways in healthcare.

Best Scientists Citing David G. DeNardo

Trending Scientists

Recently Published Articles